Cancer BiologybioRxivPreprint
PRMT5 as an Epigenetic Target for Group 3 (MYC-driven) Medulloblastoma
Devendra Kumar, Ajay Sharma, Amit K. Dash…·Nagendra K. Chaturvedi
This study identifies PRMT5 as an epigenetic regulator of MYC transcription and oncogenic programs in Group 3 medulloblastoma, showing that its inhibition suppresses tumor growth and prolongs survival in mouse models.
DOI 10.64898/2026.04.09.717536